Return
Progress Toward Hepatitis C Elimination Among People Who Inject Drugs in San Francisco, 2018 – 2024
C
B
G
E
W
DOI:10.1016/j.drugalcdep.2026.113241.png)
Abstract
En 中文
• Active HCV infection among PWID in San Francisco declined 2018–2024 • Treatment uptake increased among PWID reporting prior HCV diagnosis • Stimulant injection increased while opioid injection declined over time • Black PWID showed steeper declines in HCV infection than White PWID • Screening declined, highlighting gaps in HCV elimination efforts
Journal
IF:
3.6
Papers:
1.2W
Citations:
2.4W
